Sympathetic hyperactivity and relative NO deficiency are characteristic alterations in both genetic and salt hypertension. The contribution of these abnormalities to blood pressure (BP) maintenance can be determined in conscious rats using a consecutive blockade of particular vasoactive systems. Thus, the contribution of pressor effects of angiotensin II to the maintenance of high BP is usually small, but the role of renin-angiotensin system in the development of hypertension mediated by central and peripheral effects of angiotensin II on sympathetic activity is highly important. This is even true in angiotensin-dependent hypertension of heterozygous Ren-2 transgenic rats in which sympathetic hyperactivity is increasing with age. Central sympathoexcitation in this hypertensive model can be inhibited by lower losartan doses than peripheral angiotensin II-dependent vasoconstriction. This experimental model also yielded important knowledge on nephroprotective effects of new therapeutic drugs - endothelin receptor type A blockers. A considerable part of sympathetic vasoconstriction is dependent on the interaction of Ca2+ sensitization (RhoA/Rho kinase pathway) and Ca2+ influx (through L-VDCC). The blockade of these pathways prevents a major part of sympathetic vasoconstriction. Ca2+ sensitization seems to be attenuated in genetic hypertension in order to compensate increased Ca2+ influx. In contrast, enhanced Ca2+ sensitization is a hallmark of salt sensitivity in Dahl rats in which salt hypertension is dependent on increased Ca2+ influx. The attention should also be paid to the impairment of arterial baroreflex sensitivity which permits enhanced BP responses to pressor or depressor stimuli. Some abnormalities can be studied in blood vessels isolated from hypertensive rats but neither conduit arteries nor mesenteric resistance arteries represent the vascular beds decisive for the increased peripheral resistance and high BP. Keywords: Sympathetic vasoconstriction, NO-dependent vasodilatation, Calcium sensitization, Calcium influx, Arterial baroreflex, Spontaneously hypertensive rats, Salt hypertensive Dahl rats, Ren-2 transgenic rats, RAS blockade, SNS blockade, NOS inhibition, Endothelin, Vascular contraction and relaxation, Isolated conduit and resistance arteries, EDCF, PGI2, BKCa channels.

Laboratory of Experimental Hypertension Institute of Physiology Czech Academy of Sciences Prague Czech Republic

Zobrazit více v PubMed

Zicha J, Štolba P, Pohlová I, Kunes J, Jelínek J. A different role of digoxin-like factor in the maintenance of elevated blood pressure in rats treated with DOCA and saline in youth or only in adulthood. J Hypertens. 1984;2(Suppl 3):S481–S483. PubMed

Zicha J, Kuneš J, Štolba P. Endogenous digoxin-like factor contributes to the elevation of systemic resistance in rats exposed to high salt intake from prepuberty. J Hypertens. 1985;3(Suppl 3):S17–S19. PubMed

Kuneš J, Štolba P, Pohlová I, Jelínek J, Zicha J. The importance of endogenous digoxin-like factors in rats with various forms of experimental hypertension. Clin Exp Hypertens A. 1985;7:707–720. doi: 10.3109/10641968509077222. PubMed DOI

Zicha J, Kuneš J, Jelínek J. Experimental hypertension in young and adult animals. Hypertension. 1986;8:1096–1104. doi: 10.1161/01.HYP.8.12.1096. PubMed DOI

Zicha J, Kuneš J, Lébl M, Pohlová I, Slaninová J, Jelínek J. Antidiuretic and pressor actions of vasopressin in age-dependent DOCA-salt hypertension. Am J Physiol. 1989;256:R138–R145. doi: 10.1152/ajpregu.1989.256.1.R138. PubMed DOI

Zicha J, Kuneš J, Lébl M, Pohlová I, Jelínek J. Haemodynamics and the participation of pressor systems in young and adult rats with age-dependent DOCA-salt hypertension. Physiol Bohemoslov. 1987;36:89–92. PubMed

Zicha J, Byšková E, Kuneš J, Pohlová I, Jelínek J. Sodium pump activity in young and adult salt hypertensive Dahl rats. Klin Wochenschr. 1987;65(Suppl 8):76–81. PubMed

Kuneš J, Zicha J, Hamet P. Effects of dietary calcium on the development of salt hypertension in young and adult Dahl rats. J Hypertens. 1988;6(Suppl 4):S225–S227. doi: 10.1097/00004872-198812040-00067. PubMed DOI

Zicha J, Dobešová Z, Vokurková M, Rauchová H, Hojná S, Kadlecová M, Behuliak M, Vaněčková I, Kuneš J. Age-dependent salt hypertension in Dahl rats: fifty years of research. Physiol Res. 2012;61(Suppl 1):S35–S87. doi: 10.33549/physiolres.932363. PubMed DOI

Nedvídek J, Zicha J. Age-dependent changes of baroreflex efficiency in Dahl rats: effects of high salt intake. Physiol Res. 1993;42:209–212. PubMed

Nedvídek J, Zicha J. Baroreflex control of heart rate in young and adult salt hypertensive inbred Dahl rats. Physiol Res. 2000;49:323–330. doi: 10.33549/physiolres.930000.49.323. PubMed DOI

Zicha J, Dobešová Z, Kuneš J. Relative deficiency of nitric oxide-dependent vasodilation in salt-hypertensive Dahl rats: the possible role of superoxide anions. J Hypertens. 2001;19:247–254. doi: 10.1097/00004872-200102000-00011. PubMed DOI

Kuneš J, Dobešová Z, Zicha J. Altered balance of main vasopressor and vasodepressor systems in rats with genetic hypertension and hypertriglyceridaemia. Clin Sci (Lond) 2002;102:269–277. doi: 10.1042/cs1020269. PubMed DOI

Minami N, Imai Y, Hashimoto J, Abe K. Contribution of vascular nitric oxide to basal blood pressure in conscious spontaneously hypertensive rats and normotensive Wistar Kyoto rats. Clin Sci (Lond) 1995;89:177–182. doi: 10.1042/cs0890177. PubMed DOI

Jaroš F, Straka T, Dobešová Z, Pintérová M, Chalupský K, Kuneš J, Entlicher G, Zicha J. Vasorelaxant activity of some oxime derivatives. Eur J Pharmacol. 2007;575:122–126. doi: 10.1016/j.ejphar.2007.07.040. PubMed DOI

Bencze M, Behuliak M, Zicha J. The impact of four different classes of anesthetics on the mechanisms of blood pressure regulation in normotensive and spontaneously hypertensive rats. Physiol Res. 2013;62:471–478. doi: 10.33549/physiolres.932637. PubMed DOI

Kuneš J, Hojná S, Kadlecová M, Dobešsová Z, Rauchová H, Vokurková M, Loukotová J, Pecháňová O, Zicha J. Altered balance of vasoactive systems in experimental hypertension: the role of relative NO deficiency. Physiol Res. 2004;53(Suppl 1):S23–S34. doi: 10.33549/physiolres.930000.53.S23. PubMed DOI

Dobešová Z, Kuneš J, Zicha J. The altered balance between sympathetic nervous system and nitric oxide in salt hypertensive Dahl rats: ontogenetic and F2 hybrid studies. J Hypertens. 2002;20:945–955. doi: 10.1097/00004872-200205000-00030. PubMed DOI

Pecháňová O, Dobešová Z, Čejka J, Kuneš J, Zicha J. Vasoactive systems in L-NAME hypertension: the role of inducible nitric oxide synthase. J Hypertens. 2004;22:167–173. doi: 10.1097/00004872-200401000-00026. PubMed DOI

Kuneš J, Dobešová Z, Musilová A, Zídek V, Vorlíček J, Pravenec M, Křen V, Zicha J. Hemodynamic characterization of recombinant inbred strains: twenty years later. Hypertens Res. 2008;31:1659–1668. doi: 10.1291/hypres.31.1659. PubMed DOI

Pravenec M, Klír P, Křen V, Zicha J, Kuneš J. An analysis of spontaneous hypertension in spontaneously hypertensive rats by means of new recombinant inbred strains. J Hypertens. 1989;7:217–221. doi: 10.1097/00004872-198903000-00008. PubMed DOI

Zicha J, Dobešová Z, Behuliak M, Pintérová M, Kuneš J, Vaněčková I. Nifedipine-sensitive blood pressure component in hypertensive models characterized by high activity of either sympathetic nervous system or renin-angiotensin system. Physiol Res. 2014;63:13–26. doi: 10.33549/physiolres.932717. PubMed DOI

Behuliak M, Pintérová M, Kuneš J, Zicha J. Vasodilator efficiency of endogenous prostanoids, Ca2+-activated K+ channels and nitric oxide in rats with spontaneous, salt-dependent or NO-deficient hypertension. Hypertens Res. 2011;34:968–975. doi: 10.1038/hr.2011.82. PubMed DOI

Zicha J, Dobešová Z, Behuliak M, Kuneš J, Vaněčková I. Preventive dietary potassium supplementation in young salt-sensitive Dahl rats attenuates development of salt hypertension by decreasing sympathetic vasoconstriction. Acta Physiol (Oxf) 2011;202:29–38. doi: 10.1111/j.1748-1716.2010.02248.x. PubMed DOI

Zicha J, Dobešová Z, Kuneš J, Vaněčková I. Chronic endothelin A receptor blockade attenuates contribution of sympathetic nervous system to salt hypertension development in adult but not in young Dahl rats. Acta Physiol (Oxf) 2012;205:124–132. doi: 10.1111/j.1748-1716.2011.02395.x. PubMed DOI

Vaněčková I, Vokurková M, Rauchová H, Dobešová Z, Pecháňová O, Kuneš J, Vorlíček J, Zicha J. Chronic antioxidant therapy lowers blood pressure in adult but not in young Dahl salt hypertensive rats: the role of sympathetic nervous system. Acta Physiol (Oxf) 2013;208:340–349. doi: 10.1111/apha.12092. PubMed DOI

Rauchová H, Pecháňová O, Kuneš J, Vokurková M, Dobešová Z, Zicha J. Chronic N-acetylcysteine administration prevents development of hypertension in Nω-nitro-L-arginine methyl ester-treated rats: the role of reactive oxygen species. Hypertens Res. 2005;28:475–482. doi: 10.1291/hypres.28.475. PubMed DOI

Zicha J, Dobešová Z, Kuneš J. Antihypertensive mechanisms of chronic captopril or N-acetylcysteine treatment in L-NAME hypertensive rats. Hypertens Res. 2006;29:1021–1027. doi: 10.1291/hypres.29.1021. PubMed DOI

Pecháňová O, Zicha J, Kojšová S, Dobešová Z, Jendeková L, Kuneš J. Effect of chronic N-acetylcysteine treatment on the development of spontaneous hypertension. Clin Sci (Lond) 2006;110:235–242. doi: 10.1042/CS20050227. PubMed DOI

Pecháňová O, Zicha J, Paulis L, Zenebe W, Dobešová Z, Kojšová S, Jendeková L, Sládková M, Dovinová I, Šimko F, Kuneš J. The effect of N-acetylcysteine and melatonin in adult spontaneously hypertensive rats with established hypertension. Eur J Pharmacol. 2007;561:129–136. doi: 10.1016/j.ejphar.2007.01.035. PubMed DOI

Zicha J. Cellular sodium and calcium in experimental hypertension. Physiol Res. 1991;40:261–277. PubMed

Zicha J, Kuneš J. Membrane defects and the development of hypertension. In: McCarty R, Blizard DA, Chevalier RL, editors. Handbook of Hypertension, Vol. 19, Development of Hypertensive Phenotype: Basic and Clinical Studies. Elsevier; Amsterdam: 1999. pp. 213–251.

Zicha J, Kuneš J, Devynck MA. Abnormalities of membrane function and lipid metabolism in hypertension: a review. Am J Hypertens. 1999;12:315–331. doi: 10.1016/S0895-7061(98)00178-2. PubMed DOI

Loukotová J, Kuneš J, Zicha J. Gender-dependent difference in cell calcium handling in VSMC isolated from SHR: the effect of angiotensin II. J Hypertens. 2002;20:2213–2219. doi: 10.1097/00004872-200211000-00021. PubMed DOI

Paulis L, Líšková S, Pintérová M, Dobešová Z, Kuneš J, Zicha J. Nifedipine-sensitive noradrenergic vasoconstriction is enhanced in spontaneously hypertensive rats: the influence of chronic captopril treatment. Acta Physiol (Oxf) 2007;191:255–266. doi: 10.1111/j.1748-1716.2007.01737.x. PubMed DOI

Pintérová M, Líšková S, Dobešová Z, Behuliak M, Kuneš J, Zicha J. Impaired control of L-type voltage-dependent calcium channels in experimental hypertension. Physiol Res. 2009;58(Suppl 2):S43–S54. doi: 10.33549/physiolres.931914. PubMed DOI

Kuneš J, Dobešová Z, Zicha J. Angiotensin-dependent sympathetic vasoconstriction in SHR: the effect of captopril treatment in young animals. J Hypertens. 2006;23(Suppl 2):S234.

Zicha J, Dobešová Z, Kuneš J. Late blood pressure reduction in SHR subjected to transient captopril treatment in youth: possible mechanisms. Physiol Res. 2008;57:495–498. doi: 10.33549/physiolres.931615. PubMed DOI

Harrap SB, Van der Merwe WM, Griffin SA, Macpherson F, Lever AF. Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term. Hypertension. 1990;16:603–614. doi: 10.1161/01.HYP.16.6.603. PubMed DOI

Pintérová M, Karen P, Kuneš J, Zicha J. Role of nifedipine-sensitive sympathetic vasoconstriction in maintenance of high blood pressure in spontaneously hypertensive rats: effect of Gi-protein inactivation by pertussis toxin. J Hypertens. 2010;28:969–978. doi: 10.1097/HJH.0b013e328335dd49. PubMed DOI

Líšková S, Kuneš J, Zicha J. Nifedipine-sensitive vascular reactivity of femoral arteries in WKY: the effects of pertussis toxin pretreatment and endothelium removal. Physiol Res. 2007;56:663–666. doi: 10.33549/physiolres.931367. PubMed DOI

Pintérová M, Behuliak M, Kuneš J, Zicha J. Involvement of BKCa and KV potassium channels in cAMP-induced vasodilatation: their insufficient function in genetic hypertension. Physiol Res. 2014;63:275–285. doi: 10.33549/physiolres.932718. PubMed DOI

Vaněčková I, Dobešová Z, Kuneš J, Zicha J. The effects of repeated delivery of angiotensin II AT1 receptor antisense on distinct vasoactive systems in Ren-2 transgenic rats: young vs. adult animals. Hypertens Res. 2012;35:761–768. doi: 10.1038/hr.2012.29. PubMed DOI

Vaněčková I, Dobešová Z, Kuneš J, Vernerová Z, Zicha J. Endothelin A receptor blocker atrasentan lowers blood pressure by the reduction of nifedipine-sensitive calcium influx in Ren-2 transgenic rats fed a high-salt diet. J Hypertens. 2015;33:161–169. doi: 10.1097/HJH.0000000000000357. PubMed DOI

Vaněčková I, Řezáčová L, Kuneš J, Zicha J. Moderate additive effects of endothelin receptor A blockade in Ren-2 transgenic rats subjected to various types of RAS blockade. Life Sci. 2016;159:127–134. doi: 10.1016/j.lfs.2016.01.020. PubMed DOI

Vaněčková I, Kujal P, Husková Z, Vaňourková Z, Vernerová Z, Čertíková Chábová V, Škaroupková P, Kramer HJ, Tesař V, Červenka L. Effects of combined endothelin A receptor and renin-angiotensin system blockade on the course of end-organ damage in 5/6 nephrectomized Ren-2 hypertensive rats. Kidney Blood Press Res. 2012;35:382–392. doi: 10.1159/000336823. PubMed DOI

Čertíková Chábová V, Vernerová Z, Kujal P, Husková Z, Škaroupková P, Tesař V, Kramer HJ, Kompanowska-Jezierska E, Walkowska A, Sadowski J, Červenka L, Vaněčková I. Addition of ETA receptor blockade increases renoprotection provided by renin-angiotensin system blockade in 5/6 nephrectomized Ren-2 transgenic rats. Life Sci. 2014;118:297–305. doi: 10.1016/j.lfs.2013.12.018. PubMed DOI

Sedláková L, Čertíková Chábová V, Doleželová Š, Škaroupková P, Kopkan L, Husková Z, Červenková L, Kikerlová S, Vaněčková I, Sadowski J, Kompanowska-Jezierska E, Kujal P, Kramer HJ, Červenka L. Renin-angiotensin system blockade alone or combined with ETA receptor blockade: effects on the course of chronic kidney disease in 5/6 nephrectomized Ren-2 transgenic hypertensive rats. Clin Exp Hypertens. 2017;39:183–195. doi: 10.1080/10641963.2016.1235184. PubMed DOI

Čertíková Chábová V, Kujal P, Vaňourková Z, Škaroupková P, Sadowski J, Kompanowska-Jezierska E, Tesař V, Hammock B, Imig J, Maxová H, Červenka L, Vaněčková I. Addition of endothelin A-receptor blockade spoils the beneficial effect of combined renin-angiotensin and soluble epoxide hydrolase inhibition: studies on the course of chronic kidney disease in 5/6 nephrectomized Ren-2 transgenic hypertensive rats. Kidney Blood Press Res. 2019;44:1493–1505. doi: 10.1159/000504137. PubMed DOI PMC

Kala P, Gawrys O, Miklovič M, Vaňourková Z, Škaroupková P, Jíchová Š, Sadowski J, Kompanowska-Jezierska E, Walkowska A, Veselka J, Táborský M, Maxová H, Vaněčková I, Červenka L. Endothelin type A receptor blockade attenuates aorto-caval fistula-induced heart failure in rats with angiotensin II-dependent hypertension. J Hypertens. 2023;41:99–114. doi: 10.1097/01.hjh.0000917496.33970.53. PubMed DOI PMC

Kala P, Vaňourková Z, Škaroupková P, Kompanowska-Jezierska E, Sadowski J, Walkowska A, Veselka J, Táborský M, Maxová H, Vaněčková I, Červenka L. Endothelin type A receptor blockade increases renoprotection in congestive heart failure combined with chronic kidney disease: Studies in 5/6 nephrectomized rats with aorto-caval fistula. Biomed Pharmacother. 2023;158:114157. doi: 10.1016/j.biopha.2022.114157. PubMed DOI

Řezáčová L, Hojná S, Kopkan L, Rauchová H, Kadlecová M, Zicha J, Vaněčková I. Role of angiotensin II in chronic blood pressure control of heterozygous Ren-2 transgenic rats: Peripheral vasoconstriction versus central sympathoexcitation. Biomed Pharmacother. 2019;116:108996. doi: 10.1016/j.biopha.2019.108996. PubMed DOI

Řezáčová L, Vaněčková I, Hojná S, Vavřínová A, Valovič P, Rauchová H, Behuliak M, Zicha J. Both central sympathoexcitation and peripheral angiotensin II-dependent vasoconstriction contribute to hypertension development in immature heterozygous Ren-2 transgenic rats. Hypertens Res. 2022;45:414–423. doi: 10.1038/s41440-021-00775-2. PubMed DOI

Zicha J, Řezáčová L, Behuliak M, Vaněčková I. Blood pressure reduction induced by chronic intracerebroventricular or peroral clonidine administration in rats with salt-dependent or angiotensin II-dependent hypertension. Physiol Res. 2022;71:763–770. doi: 10.33549/physiolres.935041. PubMed DOI PMC

Behuliak M, Pintérová M, Bencze M, Petrová M, Líšková S, Karen P, Kuneš J, Vaněčková I, Zicha J. Ca2+ sensitization and Ca2+ entry in the control of blood pressure and adrenergic vasoconstriction in conscious Wistar-Kyoto and spontaneously hypertensive rats. J Hypertens. 2013;31:2025–2035. doi: 10.1097/HJH.0b013e328362adb3. PubMed DOI

Zicha J, Behuliak M, Pintérová M, Bencze M, Kuneš J, Vaněčková I. The interaction of calcium entry and calcium sensitization in the control of vascular tone and blood pressure of normotensive and hypertensive rats. Physiol Res. 2014;63(Suppl 1):S19–S27. doi: 10.33549/physiolres.932639. PubMed DOI

Behuliak M, Vavřínová A, Bencze M, Polgárová K, Ergang P, Kuneš J, Vaněčková I, Zicha J. Ontogenetic changes in contribution of calcium sensitization and calcium entry to blood pressure maintenance of Wistar-Kyoto and spontaneously hypertensive rats. J Hypertens. 2015;33:2443–2454. doi: 10.1097/HJH.0000000000000746. PubMed DOI

Brunová A, Bencze M, Behuliak M, Zicha J. Acute and chronic role of nitric oxide, renin-angiotensin system and sympathetic nervous system in the modulation of calcium sensitization in Wistar rats. Physiol Res. 2015;64:447–457. doi: 10.33549/physiolres.933094. PubMed DOI

Behuliak M, Bencze M, Vaněčková I, Kuneš J, Zicha J. Basal and activated calcium sensitization mediated by RhoA/Rho kinase pathway in rats with genetic and salt hypertension. Biomed Res Int. 2017;2017:8029728. doi: 10.1155/2017/8029728. PubMed DOI PMC

Vaněčková I, Behuliak M, Hojná S, Kopkan L, Kadlecová M, Zicha J. Exaggerated blood pressure response to fasudil or nifedipine in hypertensive Ren-2 transgenic rats: role of altered baroreflex. Hypertens Res. 2019;42:145–154. doi: 10.1038/s41440-018-0146-x. PubMed DOI

Zicha J, Behuliak M, Vavřínová A, Dobešová Z, Kuneš J, Rauchová H, Vaněčková I. Cooperation of augmented calcium sensitization and increased calcium entry contributes to high blood pressure in salt-sensitive Dahl rats. Hypertens Res. 2021;44:1067–1078. doi: 10.1038/s41440-021-00659-5. PubMed DOI

Paulis L, Zicha J, Kunes J, Hojna S, Behuliak M, Celec P, Kojsova S, Pechanova O, Simko F. Regression of L-NAME-induced hypertension: the role of nitric oxide and endothelium-derived constricting factor. Hypertens Res. 2008;31:793–803. doi: 10.1291/hypres.31.793. PubMed DOI

Paulis L, Pechanova O, Zicha J, Barta A, Gardlik R, Celec P, Kunes J, Simko F. Melatonin interactions with blood pressure and vascular function during L-NAME-induced hypertension. J Pineal Res. 2010;48:102–108. doi: 10.1111/j.1600-079X.2009.00732.x. PubMed DOI

Paulis L, Pechanova O, Zicha J, Liskova S, Celec P, Mullerova M, Kollar J, Behuliak M, Kunes J, Adamcova M, Simko F. Melatonin improves the restoration of endothelium-derived constricting factor signalling and inner diameter in the rat femoral artery after cessation of L-NAME treatment. J Hyperten. 2010;28(Suppl 1):S19–S24. doi: 10.1097/01.hjh.0000388490.28213.de. PubMed DOI

Líšková S, Petrová M, Karen P, Kuneš J, Zicha J. Influence of calcium-dependent potassium channel blockade and nitric oxide inhibition on norepinephrine-induced contractions in two forms of genetic hypertension. J Am Soc Hypertens. 2010;4:128–134. doi: 10.1016/j.jash.2010.02.006. PubMed DOI

Líšková S, Petrová M, Karen P, Kuneš J, Zicha J. Effects of aging and hypertension on the participation of endothelium-derived constricting factor (EDCF) in norepinephrine-induced contraction of rat femoral artery. Eur J Pharmacol. 2011;667:265–270. doi: 10.1016/j.ejphar.2011.05.031. PubMed DOI

Líšková S, Petrová M, Karen P, Behuliak M, Zicha J. Contribution of Ca2+-dependent Cl− channels to norepinephrine-induced contraction of femoral artery is replaced by increasing EDCF contribution during ageing. Biomed Res Int. 2014;2014:289361. doi: 10.1155/2014/289361. PubMed DOI PMC

Bencze M, Behuliak M, Vavřínová A, Zicha J. Altered contractile responses of arteries from spontaneously hypertensive rat: The role of endogenous mediators and membrane depolarization. Life Sci. 2016;166:46–53. doi: 10.1016/j.lfs.2016.10.005. PubMed DOI

Valovič P, Behuliak M, Vaněčková I, Zicha J. Impaired vascular β-adrenergic relaxation in spontaneously hypertensive rats: The differences between conduit and resistance arteries. Eur J Pharmacol. 2023;958:176045. doi: 10.1016/j.ejphar.2023.176045. PubMed DOI

Behuliak M, Bencze M, Polgárová K, Kuneš J, Vaněčková I, Zicha J. Hemodynamic Response to Gabapentin in Conscious Spontaneously Hypertensive Rats. Hypertension. 2018;72:676–685. doi: 10.1161/HYPERTENSIONAHA.118.09909. PubMed DOI

Bencze M, Behuliak M, Vavřínová A, Zicha J. Broad-range TRP channel inhibitors (2-APB, flufenamic acid, SKF-96365) affect differently contraction of resistance and conduit femoral arteries of rat. Eur J Pharmacol. 2015;765:533–540. doi: 10.1016/j.ejphar.2015.09.014. PubMed DOI

Misárková E, Behuliak M, Bencze M, Zicha J. Excitation-contraction coupling and excitation-transcription coupling in blood vessels: their possible interactions in hypertensive vascular remodeling. Physiol Res. 2016;65:173–191. doi: 10.33549/physiolres.933317. PubMed DOI

Bannister JP, Adebiyi A, Zhao G, Narayanan D, Thomas CM, Feng JY, Jaggar JH. Smooth muscle cell α2δ-1 subunits are essential for vasoregulation by CaV1.2 channels. Circ Res. 2009;105:948–955. doi: 10.1161/CIRCRESAHA.109.203620. PubMed DOI PMC

Bannister JP, Bulley S, Narayanan D, Thomas-Gatewood C, Luzny P, Pachuau J, Jaggar JH. Transcriptional upregulation of α2δ-1 elevates arterial smooth muscle cell voltage-dependent Ca2+ channel surface expression and cerebrovascular constriction in genetic hypertension. Hypertension. 2012;60:1006–1015. doi: 10.1161/HYPERTENSIONAHA.112.199661. PubMed DOI PMC

Vavřínová A, Behuliak M, Bencze M, Vaněčková I, Zicha J. Which sympathoadrenal abnormalities of adult spontaneously hypertensive rats can be traced to a prehypertensive stage? Hypertens Res. 2019;42:949–959. doi: 10.1038/s41440-018-0198-y. PubMed DOI

Vavřínová A, Behuliak M, Bencze M, Vodička M, Ergang P, Vaněčková I, Zicha J. Sympathectomy-induced blood pressure reduction in adult normotensive and hypertensive rats is counteracted by enhanced cardiovascular sensitivity to vasoconstrictors. Hypertens Res. 2019;42:1872–1882. doi: 10.1038/s41440-019-0319-2. PubMed DOI

Vavřínová A, Behuliak M, Vaněčková I, Zicha J. The abnormalities of adrenomedullary hormonal system in genetic hypertension: Their contribution to altered regulation of blood pressure. Physiol Res. 2021;70:307–326. doi: 10.33549/physiolres.934687. PubMed DOI PMC

Behuliak M, Bencze M, Boroš A, Vavřínová A, Vodička M, Ergang P, Vaněčková I, Zicha J. Chronic inhibition of angiotensin converting enzyme lowers blood pressure in spontaneously hypertensive rats by attenuation of sympathetic tone: The role of enhanced baroreflex sensitivity. Biomed Pharmacother. 2024;176:116796. doi: 10.1016/j.biopha.2024.116796. PubMed DOI

Bencze M, Boroš A, Behuliak M, Vavřínová A, Vaněčková I, Zicha J. Changes in cardiovascular autonomic control induced by chronic inhibition of acetylcholinesterase during pyridostigmine or donepezil treatment of spontaneously hypertensive rats. Eur J Pharmacol. 2024;971:176526. doi: 10.1016/j.ejphar.2024.176526. PubMed DOI

Vavřínová A, Behuliak M, Vodička M, Bencze M, Ergang P, Vaněčková I, Zicha J. More efficient adaptation of cardiovascular response to repeated restraint in spontaneously hypertensive rats: the role of autonomic nervous system. Hypertens Res. 2024;47:2377–2392. doi: 10.1038/s41440-024-01765-w. PubMed DOI PMC

Vodička M, Vavřínová A, Mikulecká A, Zicha J, Behuliak M. Hyper-reactivity of HPA axis in Fischer 344 rats is associated with impaired cardiovascular and behavioral adaptation to repeated restraint stress. Stress. 2020;23:667–677. doi: 10.1080/10253890.2020.1777971. PubMed DOI